nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.0959	0.11	CbGpPWpGaD
Propericiazine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.0931	0.107	CbGpPWpGaD
Propericiazine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.0867	0.0995	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0248	0.0285	CbGpPWpGaD
Propericiazine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0212	0.0243	CbGpPWpGaD
Propericiazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0211	0.0242	CbGpPWpGaD
Propericiazine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0206	0.0236	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0203	0.0233	CbGpPWpGaD
Propericiazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0196	0.0225	CbGpPWpGaD
Propericiazine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0192	0.022	CbGpPWpGaD
Propericiazine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0178	0.0204	CbGpPWpGaD
Propericiazine—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0173	0.0199	CbGpPWpGaD
Propericiazine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0173	0.0198	CbGpPWpGaD
Propericiazine—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0168	0.0193	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0168	0.0193	CbGpPWpGaD
Propericiazine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0161	0.0185	CbGpPWpGaD
Propericiazine—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0157	0.018	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0146	0.0167	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0143	0.0164	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0142	0.0162	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0139	0.016	CbGpPWpGaD
Propericiazine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0134	0.0154	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0132	0.0151	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0129	0.0149	CbGpPWpGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.012	0.0138	CbGpPWpGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0117	0.0134	CbGpPWpGaD
Propericiazine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0113	0.0129	CbGpPWpGaD
Propericiazine—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.011	0.0126	CbGpPWpGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0109	0.0125	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00924	0.0106	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00907	0.0104	CbGpPWpGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00762	0.00875	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00499	0.00573	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00485	0.00556	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00451	0.00518	CbGpPWpGaD
Propericiazine—Domperidone—DRD3—Gilles de la Tourette syndrome	0.00441	0.0444	CrCbGaD
Propericiazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00413	0.14	CbGeAlD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00409	0.00469	CbGpPWpGaD
Propericiazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.00402	0.0406	CrCbGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00397	0.00455	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0037	0.00424	CbGpPWpGaD
Propericiazine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00365	0.124	CbGeAlD
Propericiazine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00351	0.119	CbGeAlD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0035	0.00402	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0034	0.0039	CbGpPWpGaD
Propericiazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.0034	0.115	CbGeAlD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00335	0.00384	CbGpPWpGaD
Propericiazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00327	0.111	CbGeAlD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00325	0.00373	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00317	0.00363	CbGpPWpGaD
Propericiazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.00313	0.0316	CrCbGaD
Propericiazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.00306	0.0309	CrCbGaD
Propericiazine—Domperidone—DRD2—Gilles de la Tourette syndrome	0.00305	0.0308	CrCbGaD
Propericiazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.00303	0.0306	CrCbGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00303	0.00347	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00298	0.00342	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00289	0.00332	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00287	0.00329	CbGpPWpGaD
Propericiazine—ADRA1B—brain—Gilles de la Tourette syndrome	0.00279	0.0945	CbGeAlD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00278	0.0032	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00276	0.00317	CbGpPWpGaD
Propericiazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.00275	0.0277	CrCbGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00274	0.00315	CbGpPWpGaD
Propericiazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.00274	0.0277	CrCbGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00269	0.00309	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00268	0.00308	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00267	0.00306	CbGpPWpGaD
Propericiazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.00262	0.0264	CrCbGaD
Propericiazine—DRD1—brain—Gilles de la Tourette syndrome	0.0026	0.0881	CbGeAlD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00259	0.00298	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00259	0.00297	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00259	0.00297	CbGpPWpGaD
Propericiazine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.00255	0.0257	CrCbGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0025	0.00287	CbGpPWpGaD
Propericiazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.00247	0.0249	CrCbGaD
Propericiazine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.00247	0.0249	CrCbGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00245	0.00282	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00241	0.00277	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00237	0.00272	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0023	0.00264	CbGpPWpGaD
Propericiazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.00228	0.023	CrCbGaD
Propericiazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.00227	0.0229	CrCbGaD
Propericiazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.00226	0.0227	CrCbGaD
Propericiazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.00223	0.0225	CrCbGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00222	0.00255	CbGpPWpGaD
Propericiazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.0022	0.0221	CrCbGaD
Propericiazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.0022	0.0221	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00218	0.00251	CbGpPWpGaD
Propericiazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.00217	0.0219	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00214	0.00246	CbGpPWpGaD
Propericiazine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.00213	0.0214	CrCbGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00212	0.00243	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00212	0.00243	CbGpPWpGaD
Propericiazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.0021	0.0212	CrCbGaD
Propericiazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.002	0.0201	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00198	0.00227	CbGpPWpGaD
Propericiazine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.00197	0.0198	CrCbGaD
Propericiazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.0019	0.0191	CrCbGaD
Propericiazine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00189	0.0643	CbGeAlD
Propericiazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.00183	0.0184	CrCbGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00182	0.00208	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0018	0.00207	CbGpPWpGaD
Propericiazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.00176	0.0178	CrCbGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00175	0.00201	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00175	0.00201	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00173	0.00198	CbGpPWpGaD
Propericiazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.00172	0.0174	CrCbGaD
Propericiazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.00172	0.0173	CrCbGaD
Propericiazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.0017	0.0171	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.0017	0.0171	CrCbGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00169	0.00194	CbGpPWpGaD
Propericiazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.00167	0.0169	CrCbGaD
Propericiazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.00164	0.0165	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00163	0.00187	CbGpPWpGaD
Propericiazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.00156	0.0157	CrCbGaD
Propericiazine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00156	0.0528	CbGeAlD
Propericiazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.00154	0.0155	CrCbGaD
Propericiazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.00152	0.0153	CrCbGaD
Propericiazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00151	0.00173	CbGpPWpGaD
Propericiazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.0015	0.0151	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0015	0.00172	CbGpPWpGaD
Propericiazine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.0015	0.0509	CbGeAlD
Propericiazine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.00147	0.0148	CrCbGaD
Propericiazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.00147	0.0148	CrCbGaD
Propericiazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00146	0.00168	CbGpPWpGaD
Propericiazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.00141	0.0142	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00138	0.00159	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00137	0.00157	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00136	0.00156	CbGpPWpGaD
Propericiazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.00135	0.0136	CrCbGaD
Propericiazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0135	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00133	0.00152	CbGpPWpGaD
Propericiazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.00126	0.0127	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00124	0.00142	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00123	0.00142	CbGpPWpGaD
Propericiazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.00121	0.0122	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0012	0.00138	CbGpPWpGaD
Propericiazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.00119	0.012	CrCbGaD
Propericiazine—ADRA2A—brain—Gilles de la Tourette syndrome	0.00119	0.0404	CbGeAlD
Propericiazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.00119	0.012	CrCbGaD
Propericiazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.00117	0.0118	CrCbGaD
Propericiazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.00116	0.0117	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00114	0.00131	CbGpPWpGaD
Propericiazine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.00114	0.0115	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00112	0.00129	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00112	0.00128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00109	0.00125	CbGpPWpGaD
Propericiazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.00105	0.0105	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00102	0.00117	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00101	0.00116	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000989	0.00113	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000955	0.0011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000925	0.00106	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000921	0.00106	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	0.00092	0.00928	CrCbGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000898	0.00103	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000867	0.000995	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000837	0.00096	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000809	0.000928	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000785	0.000901	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000782	0.000897	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000731	0.000839	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00071	0.000815	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000662	0.00076	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000645	0.00074	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000643	0.000738	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000599	0.000687	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000586	0.000672	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000546	0.000627	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00053	0.000609	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000512	0.000588	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000494	0.000567	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000419	0.000481	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000346	0.000397	CbGpPWpGaD
